系统性硬化症中的近端肌无力与肌酸激酶升高:临床相关性、预后及功能影响
澳大利亚硬皮病队列研究纳入1786例系统性硬化症患者,按近端肌无力(PW)和肌酸激酶(CK)升高分为四组。同时存在PW和CK升高者占4%,其死亡风险为无PW无CK升高者的3.6倍(95%CI 1.9-6.6),单纯PW者死亡风险为2.1倍(95%CI 1.4-3.0);PW无论CK是否升高均与躯体功能受损相关。
要点
- 同时存在近端肌无力和CK升高者占4%,表现为严重的炎症性系统性硬化症表型。
- 同时存在近端肌无力和CK升高者死亡风险为无近端肌无力且无CK升高者的3.6倍(95%CI 1.9-6.6)。
- 近端肌无力无论CK是否升高均与六分钟步行距离缩短、HAQ-DI评分升高及患者报告呼吸困难增加相关。
核心结论
- 肌病的临床特征在系统性硬化症中高度流行,影响近半数研究队列。
- 仅检测近端肌无力和CK升高,即使未进行影像学或组织病理学确认系统性硬化症肌病,也能识别重要的临床关联,并与较差的功能和总体预后相关。
研究设计与样本
- 澳大利亚硬皮病队列研究,纳入至少完成一次肌酸激酶检测和近端肌力评估的系统性硬化症参与者1786例。
- 根据近端肌无力(近端肌力<5/5)和CK升高(≥140IU/L)将参与者分为四组:同时存在近端肌无力和CK升高、单纯近端肌无力、单纯CK升高、两者均无。
- 组间比较采用卡方检验、方差分析或Kruskal-Wallis检验;生存分析采用时变协变量Cox回归模型;纵向数据采用多项逻辑回归和线性回归建模。
主要发现
- 1786例参与者中,4%同时存在近端肌无力和CK升高,15%为单纯近端肌无力,24%为单纯CK升高,57%两者均无。
- 同时存在近端肌无力和CK升高者呈现严重的炎症性系统性硬化症表型,弥漫性皮肤型系统性硬化症(p<0.01)、肌腱摩擦感(p<0.01)、滑膜炎(p<0.01)和指端溃疡(p=0.03)更常见。
- 近端肌无力者(无论CK是否升高)多病共存(p<0.01)和心肺疾病最常见,包括缺血性心脏病(p<0.01)和肺动脉高压(p<0.01)。
- 抗Scl70阳性男性最常表现为单纯CK升高,无其他显著临床差异。
- 多变量模型显示,与无近端肌无力且无CK升高者相比,同时存在近端肌无力和CK升高者死亡风险增加3.6倍(95%CI 1.9-6.6,p<0.01),单纯近端肌无力者死亡风险增加2.1倍(95%CI 1.4-3.0,p<0.01);单纯CK升高者生存更好(HR 0.7,95%CI 0.4-1.1,p=0.09)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To determine the frequency, clinical correlates and implications of clinical evidence of muscle disease in systemic sclerosis (SSc). METHODS: Australian Scleroderma Cohort Study participants with ≥1 creatine kinase (CK) and proximal power assessment were subdivided according to presence of proximal weakness (PW: proximal muscle power<5/5) and CK elevation(≥140IU/L). Participants were assigned to one of four groups: concurrent PW&CK elevation, PW alone, CK elevation alone or neither. Between-group comparisons were made with chi-squared, ANOVA or Kruskal-Wallis tests. Survival analysis was performed using time-varying-covariate Cox regression modelling. Longitudinal data were modelled using multinomial logistic and linear regression. RESULTS: Of 1786 participants, 4 % had concurrent PW&CK elevation, 15 % PW alone, 24 % CK elevation and 57 % neither. Participants with PW&CK elevation displayed a severe, inflammatory SSc phenotype, with more frequent dcSSc(p < 0.01), tendon friction rubs(p < 0.01), synovitis(p < 0.01) and digital ulceration(p = 0.03). Multimorbidity(p < 0.01) and cardiopulmonary disease, including ischaemic heart disease(p < 0.01) and pulmonary arterial hypertension(p < 0.01), were most common in those with PW, with and without CK elevation. Men with anti-Scl70 positivity most frequently had CK elevation alone, without other significant clinical differences. Multivariable modelling demonstrated 3.6-fold increased mortality in those with PW&CK elevation (95 %CI 1.9-6.6, p < 0.01) and 2.1-fold increased mortality in PW alone (95 %CI 1.4-3.0, p < 0.01) compared to those without PW or CK elevation. CK elevation alone conferred better survival (HR 0.7, 95 %CI 0.4-1.1, p = 0.09) compared to those with no PW or CK elevation. PW regardless of CK elevation was associated with impaired physical function, with reduced six-minute-walk-distance (p < 0.01), higher HAQ-DI scores (p < 0.01) and increased patient-reported dyspnoea (p = 0.04). CONCLUSION: Clinical features of myopathy are highly prevalent in SSc, affecting almost half of our study cohort. Detection of PW and elevated CK alone, even without imaging or histopathological identification of SSc-myopathy, identified important clinical associations and are associated with poorer function and overall prognosis.
引用
- Fairley JL, Hansen D, Day J, et al. Proximal weakness and creatine kinase elevation in systemic sclerosis: Clinical correlates, prognosis and functional implications. Semin Arthritis Rheum. 2024. PMID: 38316069. doi:10.1016/j.semarthrit.2024.152363
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。